Terms: = Prostate cancer AND MYC, c-Myc, 4609, ENSG00000136997
1270 results:
1. Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy.
Jeon D; Hill E; Moseman JE; McNeel DG
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702146
[TBL] [Abstract] [Full Text] [Related]
2. prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation.
Soror AA; Eshagh R; Fahim MR; Jamshidian A; Monfared GH
Klin Onkol; 2024; 38(2):95-101. PubMed ID: 38697817
[TBL] [Abstract] [Full Text] [Related]
3. Transcription Factors in prostate cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches.
Silva KCS; Tambwe N; Mahfouz DH; Wium M; Cacciatore S; Paccez JD; Zerbini LF
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674385
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
5. Regulation of Molecular Biomarkers Associated with the Progression of prostate cancer.
Martin-Caraballo M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673756
[TBL] [Abstract] [Full Text] [Related]
6. Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using
Muralidhar A; Hernandez R; Morris ZS; Comas Rojas H; Bio Idrissou M; Weichert JP; McNeel DG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38663936
[TBL] [Abstract] [Full Text] [Related]
7. CDK9 inhibition activates innate immune response through viral mimicry.
Yalala S; Gondane A; Poulose N; Liang J; Mills IG; Itkonen HM
FASEB J; 2024 Apr; 38(8):e23628. PubMed ID: 38661032
[TBL] [Abstract] [Full Text] [Related]
8. The myc-associated zinc finger protein epigenetically controls expression of interferon-γ-stimulated genes by recruiting STAT1 to chromatin.
Xiao T; Li X; Felsenfeld G
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2320938121. PubMed ID: 38635637
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of the Gene Networks and Pathways Correlated with Tissue Differentiation in prostate cancer.
Filippi A; Aurelian J; Mocanu MM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612439
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.
Weiss S; Lamy P; Rusan M; Nørgaard M; Ulhøi BP; Knudsen M; Kassentoft CG; Farajzadeh L; Jensen JB; Pedersen JS; Borre M; Sørensen KD
Int J Cancer; 2024 Jul; 155(2):298-313. PubMed ID: 38602058
[TBL] [Abstract] [Full Text] [Related]
11. Development, synthesis and validation of improved c-myc/Max inhibitors.
Yıldırım S; Kocabaş F; Mermer A
J Cell Mol Med; 2024 Apr; 28(8):e18272. PubMed ID: 38568057
[TBL] [Abstract] [Full Text] [Related]
12. Mediator kinase inhibition reverses castration resistance of advanced prostate cancer.
Li J; Hilimire TA; Liu Y; Wang L; Liang J; Gyorffy B; Sikirzhytski V; Ji H; Zhang L; Cheng C; Ding X; Kerr KR; Dowling CE; Chumanevich AA; Mack ZT; Schools GP; Lim CU; Ellis L; Zi X; Porter DC; Broude EV; McInnes C; Wilding G; Lilly MB; Roninson IB; Chen M
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38546787
[TBL] [Abstract] [Full Text] [Related]
13. Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway.
Cheng B; Li L; Luo T; Wang Q; Luo Y; Bai S; Li K; Lai Y; Huang H
J Exp Clin Cancer Res; 2024 Mar; 43(1):67. PubMed ID: 38429845
[TBL] [Abstract] [Full Text] [Related]
14. myc induces CDK4/6 inhibitors resistance by promoting pRB1 degradation.
Ma J; Li L; Ma B; Liu T; Wang Z; Ye Q; Peng Y; Wang B; Chen Y; Xu S; Wang K; Dang F; Wang X; Zeng Z; Jian Y; Ren Z; Fan Y; Li X; Liu J; Gao Y; Wei W; Li L
Nat Commun; 2024 Feb; 15(1):1871. PubMed ID: 38424044
[TBL] [Abstract] [Full Text] [Related]
15. scCircle-seq unveils the diversity and complexity of extrachromosomal circular DNAs in single cells.
Chen JP; Diekmann C; Wu H; Chen C; Della Chiara G; Berrino E; Georgiadis KL; Bouwman BAM; Virdi M; Harbers L; Bellomo SE; Marchiò C; Bienko M; Crosetto N
Nat Commun; 2024 Feb; 15(1):1768. PubMed ID: 38409079
[TBL] [Abstract] [Full Text] [Related]
16. Molecular complexity of intraductal carcinoma of the prostate.
Zhu S; Xu N; Zeng H
Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
[TBL] [Abstract] [Full Text] [Related]
17. Targeting prostate tumor low-molecular weight tyrosine phosphatase for oxidation-sensitizing therapy.
Stanford SM; Nguyen TP; Chang J; Zhao Z; Hackman GL; Santelli E; Sanders CM; Katiki M; Dondossola E; Brauer BL; Diaz MA; Zhan Y; Ramsey SH; Watson PA; Sankaran B; Paindelli C; Parietti V; Mikos AG; Lodi A; Bagrodia A; Elliott A; McKay RR; Murali R; Tiziani S; Kettenbach AN; Bottini N
Sci Adv; 2024 Feb; 10(5):eadg7887. PubMed ID: 38295166
[TBL] [Abstract] [Full Text] [Related]
18. ZNF692 promotes cell proliferation, invasion and migration of human prostate cancer cells by targeting the EMT signaling pathway.
Chen H; Li Y; Wu G; Zeng Q; Huang H; Zhang G
Eur J Med Res; 2024 Jan; 29(1):88. PubMed ID: 38291502
[TBL] [Abstract] [Full Text] [Related]
19. Integrated analysis identifies GABRB3 as a biomarker in prostate cancer.
Chen JY; Chang CF; Huang SP; Huang CY; Yu CC; Lin VC; Geng JH; Li CY; Lu TL; Bao BY
BMC Med Genomics; 2024 Jan; 17(1):41. PubMed ID: 38287309
[TBL] [Abstract] [Full Text] [Related]
20. ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-myc signaling.
Zhou C; Ma H; Yu W; Zhou Y; Zhang X; Meng Y; Chen C; Zhang J; Shi G
Biochem Biophys Res Commun; 2024 Feb; 698():149543. PubMed ID: 38266312
[TBL] [Abstract] [Full Text] [Related]
[Next]
